IVIG treatment for progressive stroke in the primary antiphospholipid antibody syndrome

Abstract

A 32-year old woman with antiphospholipid antibody syndrome (APS) developed severe thrombocytopenia, elevated liver enzymes and progressive cerebral thrombosis a few days after preterm delivery by caesarean section. Her condition deteriorated despite treatment with low dose aspirin, anticoagulation by heparin and iv glucocorticoid administration. Intravenous immunoglobulin (IVIG) on three consecutive days was followed by rapid resolution of her neurological impairment and increasing platelets counts. The temporal association between IVIG and reversal of both neurological impairment and platelet number strongly indicates a specific effect of IVIG administration in this condition. It is proposed that IVIG therapy is considered as a therapeutic option in APS patients with progressive cerebral infarction despite optimal use of anticoagulant and immunomodulating agents.

Keywords

antiphospholipid antibody syndrome intravenous immunoglobulin stroke in progression

Get full access to this article

View all access options for this article.

References

Imbach P , Barandun S , d’Apuzzo et al. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood . Lancet 1981; 1: 1228-1231 .

van der Meche FG , Schmitz PI. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barre syndrome. Dutch Guillain-Barré Study Group . N Engl J Med 1992; 326: 1123-1129 .

Gajdos P , Chevret S , Clair B , Tranchant C , Chastang C. Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis. Myasthenia Gravis Clinical Study Group . Ann Neurol 1997; 41: 789-796 .

Achiron A , Gabbay U , Gilad R et al. Intravenous immunoglobulin treatment in multiple sclerosis. Effect on relapses . Neurology 1998; 50: 398-402 .

Saadeh C , Bridges W , Burwick F. Dermatomyositis: remission induced with combined oral cyclosporine and high-dose intravenous immune globulin . South Med J 1995; 88: 866-870 .

Clark AL , Branch DW , Silver RM , Harris EN , Pierangeli S , Spinnato JA. Pregnancy complicated by the antiphospholipid syndrome: outcomes with intravenous immunoglobulin therapy . Obstet Gynecol 1999; 93: 437-441 .

Cervera R , Piette JC , Font J et al. Antiphospholipid syndrome. Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1000 patients . Arthritis Rheum 2002; 46: 1019-1027 .

Atsumi T , Khamashta MA , Haworth RS et al. Arterial disease and thrombosis in the antiphospholipid syndrome: a pathogenic role for endothelin 1 . Arthritis Rheum 1998; 41: 800-807 .

Kazatchkine MD , Kaveri SV. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin . N Engl J Med 2001; 345: 747-755 .

10.

Gordon C , Kilby MD. Use of intravenous immunoglobulin therapy in pregnancy in systemic lupus erythematosus and antiphospholipid antibody syndrome . Lupus 1998; 7: 429-433 .